Panobinostat is a De-acetylator inhibitor for Histone, meaning that it paralyzes a few enzymes perinuclearly, therefore blocking Mitosis this way.
It has demonstrated Activity in Relapsed/Refractory Hodgkin's disease post transplantation. An area where it does not have much competition. And here it is actually pretty good at achieving like most target therapies a 30% effectiveness and with additional stable diseases. A respectable effectiveness.
Now it is being tried in Non Hodgkin's disease with Rituxan. We will update you on this!
A blog about research, awareness, prevention, treatment and survivorship of Breast Cancer and all cancers, including targeted scientific research and a grassroots approach to increase screening for cancer, especially in the low income and under-insured population of El Paso, Texas, with a view to expand this new health care model to many other 'minority' populations across the United States and beyond
Showing posts with label de-acetylation. Show all posts
Showing posts with label de-acetylation. Show all posts
Friday, January 18, 2013
Subscribe to:
Posts (Atom)